NDC 70748-258

POSACONAZOLE

Posaconazole

POSACONAZOLE is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is Posaconazole.

Product ID70748-258_32b94024-0ca5-4767-9c72-b1f8ec8699ae
NDC70748-258
Product TypeHuman Prescription Drug
Proprietary NamePOSACONAZOLE
Generic NamePosaconazole
Dosage FormTablet, Delayed Release
Route of AdministrationORAL
Marketing Start Date2021-02-03
Marketing CategoryANDA / ANDA
Application NumberANDA213454
Labeler NameLupin Pharmaceuticals, Inc.
Substance NamePOSACONAZOLE
Active Ingredient Strength100 mg/1
Pharm ClassesAzole Antifungal [EPC],Azoles [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 70748-258-07

60 TABLET, DELAYED RELEASE in 1 BOTTLE (70748-258-07)
Marketing Start Date2021-02-03
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "POSACONAZOLE" or generic name "Posaconazole"

NDCBrand NameGeneric Name
0254-2045POSACONAZOLEposaconazole
0406-7711POSACONAZOLEposaconazole
0527-2133POSACONAZOLEPosaconazole
60687-523PosaconazolePosaconazole
70748-258POSACONAZOLEPOSACONAZOLE
0085-1328NOXAFILposaconazole
0085-2224NOXAFILposaconazole
0085-4324NOXAFILposaconazole
0085-4331NOXAFILposaconazole

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.